Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | JAK2 | O60674 | 1/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | GLA | P06280 | 1/20 | 0.68 |
| ▸ | CTSG | P08311 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triamterene SCHEMBL40707 | 0.81 | ALDH1A1 (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Triamterene SCHEMBL29531410 | 0.81 | ALDH1A1 (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Triamterene SCHEMBL5421685 | 0.81 | ALDH1A1 (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Triamterene SCHEMBL11044581 | 0.80 | ALDH1A1 (0.97) | MTORKDM4EJAK2GMNNALDH1A1 | |
| SCHEMBL10456550 | 0.79 | PIK3CG (0.87) | MTORKDM4EJAK2GMNNALDH1A1 | |
| SCHEMBL10843457 | 0.76 | ADORA2A (0.71) | CYP2D6MAPK1PMP22CSNK1A1CLK4 | |
| Tg100-115 SCHEMBL29411790 | 0.75 | PIK3CG (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Tg100-115 SCHEMBL29361550 | 0.75 | PIK3CG (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Tg100-115 SCHEMBL360279 | 0.75 | PIK3CG (1.00) | MTORKDM4EJAK2GMNNALDH1A1 | |
| Tg100-115 SCHEMBL31238338 | 0.75 | PIK3CG (1.00) | MTORKDM4EJAK2GMNNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4346928-B1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | US HEALTH (US) | 2026-01-14 | — | — | EP | claimed |
| US-20240271089-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-08-15 | — | — | US | claimed |
| US-20240261474-A1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-08-08 | — | — | US | claimed |
| EP-4347795-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-04-10 | — | — | EP | claimed |
| EP-4346928-A1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2022251477-A1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022251499-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | claimed |
| EP-4722343-A1 | METHOD FOR PRODUCING SUPRACHIASMATIC NUCLEUS ORGANOID | Kansai Medical University Educational Corporation (JP) | 2026-04-08 | — | — | EP | disclosed |
| CN-121513013-A | Use of Epiblastin A in the manufacture of a medicament for alleviating cisplatin-induced acute kidney injury | 南京市儿童医院 | 2026-02-13 | — | — | CN | disclosed |
| CN-121513013-A | Use of Epiblastin A in the manufacture of a medicament for alleviating cisplatin-induced acute kidney injury | 南京市儿童医院 | 2026-02-13 | — | — | CN | disclosed |
| EP-4346928-B1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | US HEALTH (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250027040-A1 | METHODS FOR DIFFERENTIATING CELLS | BOND UNIVERSITY LTD (AU) | 2025-01-23 | — | — | US | disclosed |
| WO-2024248023-A1 | METHOD FOR PRODUCING SUPRACHIASMATIC NUCLEUS ORGANOID | 京都府公立大学法人 | 2024-12-05 | — | — | WO | disclosed |
| EP-4347795-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20230416676-A1 | Method for Reprogramming Cell | MOUCELLION THERAPEUTICS Ltd. (CN) | 2023-12-28 | — | — | US | disclosed |
| EP-4289941-A1 | METHOD FOR REPROGRAMMING CELL | MOUCELLION THERAPEUTICS Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| WO-2022251477-A1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022251499-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | disclosed |
| US-20220177836-A1 | METHODS FOR DIFFERENTIATING CELLS | BOND UNIVERSITY LTD (AU) | 2022-06-09 | — | — | US | disclosed |
| WO-2022110494-A1 | METHOD FOR REPROGRAMMING CELL | 北京赛尔湃腾科技咨询合伙企业(有限合伙) | 2022-06-02 | — | — | WO | disclosed |